|
GINS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.171990E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.316400E-01 |
| Normal-vs-Stage2 |
6.766400E-01 |
| Normal-vs-Stage3 |
9.944100E-02 |
| Normal-vs-Stage4 |
1.598980E-03 |
| Stage1-vs-Stage2 |
4.172600E-01 |
| Stage1-vs-Stage3 |
4.230200E-01 |
| Stage1-vs-Stage4 |
8.479700E-03 |
| Stage2-vs-Stage3 |
2.471400E-01 |
| Stage2-vs-Stage4 |
6.084900E-03 |
| Stage3-vs-Stage4 |
6.380400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.779200E-03 |
| Normal-vs-AfricanAmerican |
6.451200E-01 |
| Normal-vs-Asian |
2.426200E-01 |
| Caucasian-vs-AfricanAmerican |
1.598580E-01 |
| Caucasian-vs-Asian |
5.316600E-01 |
| AfricanAmerican-vs-Asian |
2.078000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.567960E-02 |
| Normal-vs-Female |
3.918100E-02 |
| Male-vs-Female |
5.979600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.813600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.578230E-02 |
| Normal-vs-Age(61-80Yrs) |
8.057800E-02 |
| Normal-vs-Age(81-100Yrs) |
6.928000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.439000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.625580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.114440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.808600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.111400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.787000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.402800E-01 |
| Normal-vs-Grade 2 |
1.678980E-01 |
| Normal-vs-Grade 3 |
3.572400E-02 |
| Normal-vs-Grade 4 |
6.818000E-03 |
| Grade 1-vs-Grade 2 |
9.337800E-01 |
| Grade 1-vs-Grade 3 |
5.574400E-01 |
| Grade 1-vs-Grade 4 |
6.825700E-02 |
| Grade 2-vs-Grade 3 |
2.382200E-01 |
| Grade 2-vs-Grade 4 |
2.581700E-02 |
| Grade 3-vs-Grade 4 |
1.046630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.541800E-01 |
| Normal-vs-ccB subtype |
1.643870E-02 |
| ccA subtype-vs-ccB subtype |
5.346100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.128300E-02 |
| Normal-vs-N1 |
9.776100E-03 |
| N0-vs-N1 |
1.042410E-02 |
|
|
